{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:26:46Z","timestamp":1782793606600,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1002\/3 TP A10"],"award-info":[{"award-number":["SFB 1002\/3 TP A10"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TH 1538\/3"],"award-info":[{"award-number":["TH 1538\/3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001736","name":"German-Israeli Foundation for Scientific Research and Development","doi-asserted-by":"publisher","award":["1459"],"award-info":[{"award-number":["1459"]}],"id":[{"id":"10.13039\/501100001736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001736","name":"German-Israeli Foundation for Scientific Research and Development","doi-asserted-by":"publisher","award":["1459"],"award-info":[{"award-number":["1459"]}],"id":[{"id":"10.13039\/501100001736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007952","name":"Eva Luise und Horst K\u00f6hler Stiftung","doi-asserted-by":"publisher","award":["Research Award 2016"],"award-info":[{"award-number":["Research Award 2016"]}],"id":[{"id":"10.13039\/501100007952","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005721","name":"Universit\u00e4t Bielefeld","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005721","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                <jats:title>Abstract<\/jats:title>\n                <jats:p>Rett syndrome (RTT) is a neurodevelopmental disorder resulting from genetic mutations in the <jats:italic>methyl CpG binding protein 2<\/jats:italic> (<jats:italic>MeCP2<\/jats:italic>) gene. Specifically, around 35% of RTT patients harbor premature termination codons (PTCs) within the <jats:italic>MeCP2<\/jats:italic> gene due to nonsense mutations. A promising therapeutic avenue for these individuals involves the use of aminoglycosides, which stimulate translational readthrough (TR) by causing stop codons to be interpreted as sense codons. However, the effectiveness of this treatment depends on several factors, including the type of stop codon and the surrounding nucleotides, collectively referred to as the stop codon context (SCC). Here, we develop a high-content reporter system to precisely measure TR efficiency at different SCCs, assess the recovery of the full-length <jats:italic>MeCP2<\/jats:italic> protein, and evaluate its subcellular localization. We have conducted a comprehensive investigation into the intricate relationship between SCC characteristics and TR induction, examining a total of 14 pathogenic <jats:italic>MeCP2<\/jats:italic> nonsense mutations with the aim to advance the prospects of personalized therapy for individuals with RTT. Our results demonstrate that TR induction can successfully restore full-length <jats:italic>MeCP2<\/jats:italic> protein, albeit to varying degrees, contingent upon the SCC and the specific position of the PTC within the <jats:italic>MeCP2<\/jats:italic> mRNA. TR induction can lead to the re-establishment of nuclear localization of <jats:italic>MeCP2<\/jats:italic>, indicating the potential restoration of protein functionality. In summary, our findings underscore the significance of SCC-specific approaches in the development of tailored therapies for RTT. By unraveling the relationship between SCC and TR therapy, we pave the way for personalized, individualized treatment strategies that hold promise for improving the lives of individuals affected by this debilitating neurodevelopmental disorder. <\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key messages<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>The efficiency of readthrough induction at <jats:italic>MeCP2<\/jats:italic> premature termination codons strongly depends on the stop codon context.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>The position of the premature termination codon on the transcript influences the readthrough inducibility.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>A new high-content dual reporter assay facilitates the measurement and prediction of readthrough efficiency of specific nucleotide stop contexts.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Readthrough induction results in the recovery of full-length <jats:italic>MeCP2<\/jats:italic> and its re-localization to the nucleus.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p><jats:italic>MeCP2<\/jats:italic> requires only one of its annotated nuclear localization signals.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00109-024-02436-6","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T07:01:52Z","timestamp":1709362912000},"page":"641-653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3535-2163","authenticated-orcid":false,"given":"Dennis","family":"Lebeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Fierenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Werfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Rosin-Arbesfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hofhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3018-6363","authenticated-orcid":false,"given":"Sven","family":"Thoms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,2]]},"reference":[{"key":"2436_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jpeds.2005.10.037","volume":"148","author":"CL Laurvick","year":"2006","unstructured":"Laurvick CL, de Klerk N, Bower C, Christodoulou J, Ravine D, Ellaway C, Williamson S, Leonard H (2006) Rett syndrome in Australia: a review of the epidemiology. J Pediatr 148:347\u2013352. https:\/\/doi.org\/10.1016\/j.jpeds.2005.10.037","journal-title":"J Pediatr"},{"key":"2436_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","volume":"23","author":"RE Amir","year":"1999","unstructured":"Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185\u2013188. https:\/\/doi.org\/10.1038\/13810","journal-title":"Nat Genet"},{"key":"2436_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.698812","volume":"15","author":"FD Haase","year":"2021","unstructured":"Haase FD, Coorey B, Riley L, Cantrill LC, Tam PPL, Gold WA (2021) Pre-clinical investigation of Rett syndrome using human stem cell-based disease models. Front Neurosci 15:698812. https:\/\/doi.org\/10.3389\/fnins.2021.698812","journal-title":"Front Neurosci"},{"key":"2436_CR4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.pediatrneurol.2015.06.003","volume":"53","author":"DC Tarquinio","year":"2015","unstructured":"Tarquinio DC, Hou W, Neul JL, Kaufmann WE, Glaze DG, Motil KJ, Skinner SA, Lee H-S, Percy AK (2015) The changing face of survival in Rett syndrome and MECP2-related disorders. Pediatr Neurol 53:402\u2013411. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2015.06.003","journal-title":"Pediatr Neurol"},{"key":"2436_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jmedgenet-2013-102113","volume":"51","author":"VA Cuddapah","year":"2014","unstructured":"Cuddapah VA, Pillai RB, Shekar KV, Lane JB, Motil KJ, Skinner SA, Tarquinio DC, Glaze DG, McGwin G, Kaufmann WE et al (2014) Methyl-CpG-binding protein 2 (MEPC2) mutation type is associated with disease severity in Rett Syndrome. J Med Genet 51:152\u2013158. https:\/\/doi.org\/10.1136\/jmedgenet-2013-102113","journal-title":"J Med Genet"},{"key":"2436_CR6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/humu.23263","volume":"38","author":"R Krishnaraj","year":"2017","unstructured":"Krishnaraj R, Ho G, Christodoulou J (2017) RettBASE: Rett syndrome database update. Hum Mutat 38:922\u2013931. https:\/\/doi.org\/10.1002\/humu.23263","journal-title":"Hum Mutat"},{"key":"2436_CR7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1128\/MCB.16.1.414","volume":"16","author":"X Nan","year":"1996","unstructured":"Nan X, Tate P, Li E, Bird A (1996) DNA methylation specifies chromosomal localization of MeCP2. Mol Cell Biol 16:414\u2013421. https:\/\/doi.org\/10.1128\/MCB.16.1.414","journal-title":"Mol Cell Biol"},{"key":"2436_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000315906","volume":"129","author":"LA Kifayathullah","year":"2010","unstructured":"Kifayathullah LA, Arunachalam JP, Bodda C, Agbemenyah HY, Laccone FA, Mannan AU (2010) MeCP2270 mutant protein is expressed in astrocytes as well as in neurons and localizes in the nucleus. CGR 129:290\u2013297. https:\/\/doi.org\/10.1159\/000315906","journal-title":"CGR"},{"key":"2436_CR9","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/nar\/gkh349","volume":"32","author":"S Kriaucionis","year":"2004","unstructured":"Kriaucionis S, Bird A (2004) The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res 32:1818\u20131823. https:\/\/doi.org\/10.1093\/nar\/gkh349","journal-title":"Nucleic Acids Res"},{"key":"2436_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ng1327","volume":"36","author":"GN Mnatzakanian","year":"2004","unstructured":"Mnatzakanian GN, Lohi H, Munteanu I, Alfred SE, Yamada T, MacLeod PJM, Jones JR, Scherer SW, Schanen NC, Friez MJ et al (2004) A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet 36:339\u2013341. https:\/\/doi.org\/10.1038\/ng1327","journal-title":"Nat Genet"},{"key":"2436_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13072-019-0298-1","volume":"12","author":"A Mart\u00ednez de Paz","year":"2019","unstructured":"Mart\u00ednez de Paz A, Khajavi L, Martin H, Claveria-Gimeno R, Tom Dieck S, Cheema MS, Sanchez-Mut JV, Moksa MM, Carles A, Brodie NI et al (2019) MeCP2-E1 isoform is a dynamically expressed, weakly DNA-bound protein with different protein and DNA interactions compared to MeCP2-E2. Epigenetics Chromatin 12:63. https:\/\/doi.org\/10.1186\/s13072-019-0298-1","journal-title":"Epigenetics Chromatin"},{"key":"2436_CR12","doi-asserted-by":"publisher","first-page":"624290","DOI":"10.3389\/fgene.2021.624290","volume":"12","author":"O Sharifi","year":"2021","unstructured":"Sharifi O, Yasui DH (2021) The Molecular Functions of MeCP2 in Rett Syndrome Pathology. Front Genet 12:624290. https:\/\/doi.org\/10.3389\/fgene.2021.624290","journal-title":"Front Genet"},{"key":"2436_CR13","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","volume":"70","author":"JL Neul","year":"2008","unstructured":"Neul JL, Fang P, Barrish J, Lane J, Caeg E, Smith EO, Zoghbi H, Percy A, Glaze DG (2008) Specific mutations in methyl-CpG-binding protein 2 confer different deverity in Rett syndrome. Neurology 70:1313\u20131321. https:\/\/doi.org\/10.1212\/01.wnl.0000291011.54508.aa","journal-title":"Neurology"},{"key":"2436_CR14","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1177\/0883073807308715","volume":"22","author":"AK Percy","year":"2007","unstructured":"Percy AK, Lane JB, Childers J, Skinner S, Annese F, Barrish J, Caeg E, Glaze DG, MacLeod P (2007) Rett syndrome: North American database. J Child Neurol 22:1338\u20131341. https:\/\/doi.org\/10.1177\/0883073807308715","journal-title":"J Child Neurol"},{"key":"2436_CR15","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1073\/pnas.0610593104","volume":"104","author":"E Giacometti","year":"2007","unstructured":"Giacometti E, Luikenhuis S, Beard C, Jaenisch R (2007) Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc Natl Acad Sci USA 104:1931\u20131936. https:\/\/doi.org\/10.1073\/pnas.0610593104","journal-title":"Proc Natl Acad Sci USA"},{"key":"2436_CR16","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1138389","volume":"315","author":"J Guy","year":"2007","unstructured":"Guy J, Gan J, Selfridge J, Cobb S, Bird A (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science 315:1143\u20131147. https:\/\/doi.org\/10.1126\/science.1138389","journal-title":"Science"},{"key":"2436_CR17","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1093\/hmg\/ddaa102","volume":"29","author":"JK Merritt","year":"2020","unstructured":"Merritt JK, Collins BE, Erickson KR, Dong H, Neul JL (2020) Pharmacological read-through of R294X MeCP2 in a novel mouse model of Rett syndrome. Hum Mol Genet 29:2461\u20132470. https:\/\/doi.org\/10.1093\/hmg\/ddaa102","journal-title":"Hum Mol Genet"},{"key":"2436_CR18","doi-asserted-by":"publisher","first-page":"e1912","DOI":"10.1212\/WNL.0000000000007316","volume":"92","author":"DG Glaze","year":"2019","unstructured":"Glaze DG, Neul JL, Kaufmann WE, Berry-Kravis E, Condon S, Stoms G, Oosterholt S, Della Pasqua O, Glass L, Jones NE et al (2019) Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome. Neurology 92:e1912\u2013e1925. https:\/\/doi.org\/10.1212\/WNL.0000000000007316","journal-title":"Neurology"},{"key":"2436_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.106704","volume":"114","author":"JL Neul","year":"2022","unstructured":"Neul JL, Percy AK, Benke TA, Berry-Kravis EM, Glaze DG, Peters SU, Jones NE, Youakim JM (2022) Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome. Contemp Clin Trials 114:106704. https:\/\/doi.org\/10.1016\/j.cct.2022.106704","journal-title":"Contemp Clin Trials"},{"key":"2436_CR20","doi-asserted-by":"publisher","first-page":"E10899","DOI":"10.1073\/pnas.1715501114","volume":"114","author":"I Prokhorova","year":"2017","unstructured":"Prokhorova I, Altman RB, Djumagulov M, Shrestha JP, Urzhumtsev A, Ferguson A, Chang C-WT, Yusupov M, Blanchard SC, Yusupova G (2017) Aminoglycoside interactions and impacts on the eukaryotic ribosome. Proc Natl Acad Sci USA 114:E10899\u2013E10908. https:\/\/doi.org\/10.1073\/pnas.1715501114","journal-title":"Proc Natl Acad Sci USA"},{"key":"2436_CR21","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1126\/science.1060612","volume":"292","author":"JM Ogle","year":"2001","unstructured":"Ogle JM, Brodersen DE, Clemons WM, Tarry MJ, Carter AP, Ramakrishnan V (2001) Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science 292:897\u2013902. https:\/\/doi.org\/10.1126\/science.1060612","journal-title":"Science"},{"key":"2436_CR22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S2213-2600(14)70100-6","volume":"2","author":"Kerem E, Konstan MW, De Boeck K, Accurso FJ, Sermet-Gaudelus I, Wilschanski M, Elborn JS, Melotti P, Bronsveld I, Fajac I, Malfroot A, Rosenbluth DB, Walker PA, McColley SA, Knoop C, Quattrucci S, Rietschel E, Zeitlin PL, Barth J, Elfring GL, Welch EM, Branstrom A, Spiegel RJ, Peltz SW, Ajayi T, Rowe SM, Cystic Fibrosis Ataluren Study G","year":"2014","unstructured":"Kerem E, Konstan MW, De Boeck K, Accurso FJ, Sermet-Gaudelus I, Wilschanski M, Elborn JS, Melotti P, Bronsveld I, Fajac I et al (2014) Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Respir Med 2:539\u2013547. https:\/\/doi.org\/10.1016\/S2213-2600(14)70100-6","journal-title":"Lancet Respir Med"},{"key":"2436_CR23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fped.2018.00316","volume":"6","author":"D Ebrahimi-Fakhari","year":"2018","unstructured":"Ebrahimi-Fakhari D, Dillmann U, Flotats-Bastardas M, Poryo M, Abdul-Khaliq H, Shamdeen MG, Mischo B, Zemlin M, Meyer S (2018) Off-label use of ataluren in four non-ambulatory patients with nonsense mutation Duchenne muscular dystrophy: effects on cardiac and pulmonary function and muscle strength. Front Pediatr 6:316. https:\/\/doi.org\/10.3389\/fped.2018.00316","journal-title":"Front Pediatr"},{"key":"2436_CR24","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bbadis.2017.12.014","volume":"1864","author":"A Banning","year":"2018","unstructured":"Banning A, Schiff M, Tikkanen R (2018) Amlexanox provides a potential therapy for nonsense mutations in the lysosomal storage disorder aspartylglucosaminuria. Biochim et Biophys Acta (BBA) - Mol Basis Dis 1864:668\u2013675. https:\/\/doi.org\/10.1016\/j.bbadis.2017.12.014","journal-title":"Biochim et Biophys Acta (BBA) - Mol Basis Dis"},{"key":"2436_CR25","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3390\/biom11071006","volume":"11","author":"M Schilff","year":"2021","unstructured":"Schilff M, Sargsyan Y, Hofhuis J, Thoms S (2021) Stop codon context-specific induction of translational readthrough. Biomolecules 11:1006. https:\/\/doi.org\/10.3390\/biom11071006","journal-title":"Biomolecules"},{"key":"2436_CR26","doi-asserted-by":"publisher","first-page":"e03640","DOI":"10.7554\/eLife.03640","volume":"3","author":"F Schueren","year":"2014","unstructured":"Schueren F, Lingner T, George R, Hofhuis J, Dickel C, G\u00e4rtner J, Thoms S (2014) Peroxisomal lactate dehydrogenase is generated by translational readthrough in mammals. eLife 3:e03640. https:\/\/doi.org\/10.7554\/eLife.03640","journal-title":"eLife"},{"key":"2436_CR27","doi-asserted-by":"publisher","first-page":"160246","DOI":"10.1098\/rsob.160246","volume":"6","author":"J Hofhuis","year":"2016","unstructured":"Hofhuis J, Schueren F, N\u00f6tzel C, Lingner T, G\u00e4rtner J, Jahn O, Thoms S (2016) The functional readthroughextension of malate dehydrogenase reveals a modification of the genetic code. Open Biol 6:160246. https:\/\/doi.org\/10.1098\/rsob.160246","journal-title":"Open Biol"},{"key":"2436_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2199-2-3","volume":"2","author":"M Cassan","year":"2001","unstructured":"Cassan M, Rousset JP (2001) UAG readthrough in mammalian cells: effect of upstream and downstream stop codon contexts reveal different signals. BMC Mol Biol 2:3. https:\/\/doi.org\/10.1186\/1471-2199-2-3","journal-title":"BMC Mol Biol"},{"issue":"22","key":"2436_CR29","doi-asserted-by":"publisher","first-page":"01392","DOI":"10.1016\/j.jcf.2022.10.010","volume":"S1569\u20131993","author":"IM Pranke","year":"2022","unstructured":"Pranke IM, Varilh J, Hatton A, Faucon C, Girodon E, Dreano E, Chevalier B, Karri S, Reix P, Durieu I et al (2022) The U UGA C sequence provides a favorable context to ELX-02 induced CFTR readthrough. J Cyst Fibros S1569\u20131993(22):01392\u201301393. https:\/\/doi.org\/10.1016\/j.jcf.2022.10.010","journal-title":"J Cyst Fibros"},{"key":"2436_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004685","volume":"10","author":"AC Stiebler","year":"2014","unstructured":"Stiebler AC, Freitag J, Schink KO, Stehlik T, Tillmann BAM, Ast J, B\u00f6lker M (2014) Ribosomal readthrough at a short UGA stop codon context triggers dual localization of metabolic enzymes in fungi and animals. PLoS Genet 10:e1004685. https:\/\/doi.org\/10.1371\/journal.pgen.1004685","journal-title":"PLoS Genet"},{"key":"2436_CR31","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1203\/PDR.0b013e31819d9ebc","volume":"65","author":"C Brendel","year":"2009","unstructured":"Brendel C, Klahold E, G\u00e4rtner J, Huppke P (2009) Suppression of nonsense mutations in Rett syndrome by aminoglycoside antibiotics. Pediatr Res 65:520\u2013523. https:\/\/doi.org\/10.1203\/PDR.0b013e31819d9ebc","journal-title":"Pediatr Res"},{"key":"2436_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020733","volume":"6","author":"M Vecsler","year":"2011","unstructured":"Vecsler M, Ben Zeev B, Nudelman I, Anikster Y, Simon AJ, Amariglio N, Rechavi G, Baasov T, Gak E (2011) Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations. PLoS ONE 6:e20733. https:\/\/doi.org\/10.1371\/journal.pone.0020733","journal-title":"PLoS ONE"},{"key":"2436_CR33","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/jnr.22409","volume":"88","author":"AC Popescu","year":"2010","unstructured":"Popescu AC, Sidorova E, Zhang G, Eubanks JH (2010) Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro. J Neurosci Res 88:2316\u20132324. https:\/\/doi.org\/10.1002\/jnr.22409","journal-title":"J Neurosci Res"},{"key":"2436_CR34","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/hmg\/ddp030","volume":"18","author":"CR Heier","year":"2009","unstructured":"Heier CR, DiDonato CJ (2009) Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo. Hum Mol Genet 18:1310\u20131322. https:\/\/doi.org\/10.1093\/hmg\/ddp030","journal-title":"Hum Mol Genet"},{"key":"2436_CR35","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1164\/rccm.201001-0137OC","volume":"182","author":"I Sermet-Gaudelus","year":"2010","unstructured":"Sermet-Gaudelus I, Boeck KD, Casimir GJ, Vermeulen F, Leal T, Mogenet A, Roussel D, Fritsch J, Hanssens L, Hirawat S et al (2010) Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis. Am J Respir Crit Care Med 182:1262\u20131272. https:\/\/doi.org\/10.1164\/rccm.201001-0137OC","journal-title":"Am J Respir Crit Care Med"},{"key":"2436_CR36","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1039\/C4MD00081A","volume":"5","author":"M Shalev","year":"2014","unstructured":"Shalev M, Baasov T (2014) When proteins start to make sense: fine-tuning aminoglycosides for PTC suppression therapy. Medchemcomm 5:1092\u20131105. https:\/\/doi.org\/10.1039\/C4MD00081A","journal-title":"Medchemcomm"},{"key":"2436_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-4939-6937-1_9","volume-title":"Peroxisomes: methods and protocols","author":"J Hofhuis","year":"2017","unstructured":"Hofhuis J, Dieterle S, George R, Schueren F, Thoms S (2017) Dual reporter systems for the analysis of translational readthrough in mammals. In: Schrader M (ed) Peroxisomes: methods and protocols. Springer, New York, NY, pp 81\u201392"},{"key":"2436_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2307\/2532051","volume":"45","author":"LI-K Lin","year":"1989","unstructured":"Lin LI-K (1989) A concordance correlation coefficient to evaluate reproducibility. Biometrics 45:255\u2013268. https:\/\/doi.org\/10.2307\/2532051","journal-title":"Biometrics"},{"key":"2436_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","volume":"18","author":"H Akoglu","year":"2018","unstructured":"Akoglu H (2018) User\u2019s guide to correlation coefficients. Turk J Emerg Med 18:91\u201393. https:\/\/doi.org\/10.1016\/j.tjem.2018.08.001","journal-title":"Turk J Emerg Med"},{"key":"2436_CR40","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.1128\/jvi.67.8.5062-5067.1993","volume":"67","author":"G Li","year":"1993","unstructured":"Li G, Rice CM (1993) The signal for translational readthrough of a UGA codon in Sindbis virus RNA involves a single cytidine residue immediately downstream of the termination codon. J Virol 67:5062\u20135067. https:\/\/doi.org\/10.1128\/jvi.67.8.5062-5067.1993","journal-title":"J Virol"},{"key":"2436_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13023-018-0857-8","volume":"13","author":"S Shovlin","year":"2018","unstructured":"Shovlin S, Tropea D (2018) Transcriptome level analysis in Rett syndrome using human samples from different tissues. Orphanet J Rare Dis 13:113. https:\/\/doi.org\/10.1186\/s13023-018-0857-8","journal-title":"Orphanet J Rare Dis"},{"key":"2436_CR42","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1128\/MCB.18.9.5492","volume":"18","author":"S Kudo","year":"1998","unstructured":"Kudo S (1998) Methyl-CpG-binding protein MeCP2 represses Sp1-activated transcription of the human leukosialin gene when the promoter is methylated. Mol Cell Biol 18:5492\u20135499. https:\/\/doi.org\/10.1128\/MCB.18.9.5492","journal-title":"Mol Cell Biol"},{"key":"2436_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1086\/514620","volume":"27","author":"MK Lacy","year":"1998","unstructured":"Lacy MK, Nicolau DP, Nightingale CH, Quintiliani R (1998) The pharmacodynamics of aminoglycosides. Clin Infect Dis 27:23\u201327. https:\/\/doi.org\/10.1086\/514620","journal-title":"Clin Infect Dis"},{"key":"2436_CR44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41573-019-0049-9","volume":"19","author":"E Tambuyzer","year":"2020","unstructured":"Tambuyzer E, Vandendriessche B, Austin CP, Brooks PJ, Larsson K, Miller Needleman KI, Valentine J, Davies K, Groft SC, Preti R et al (2020) Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nat Rev Drug Discov 19:93\u2013111. https:\/\/doi.org\/10.1038\/s41573-019-0049-9","journal-title":"Nat Rev Drug Discov"},{"key":"2436_CR45","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/nar\/gkac1180","volume":"51","author":"G Loughran","year":"2023","unstructured":"Loughran G, Li X, O\u2019Loughlin S, Atkins JF, Baranov PV (2023) Monitoring translation in all reading frames downstream of weak stop codons provides mechanistic insights into the impact of nucleotide and cellular contexts. Nucleic Acids Res 51:304\u2013314. https:\/\/doi.org\/10.1093\/nar\/gkac1180","journal-title":"Nucleic Acids Res"},{"key":"2436_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108399","volume":"33","author":"C Wu","year":"2020","unstructured":"Wu C, Roy B, He F, Yan K, Jacobson A (2020) Poly(A)-binding protein regulates the efficiency of translation termination. Cell Rep 33:108399. https:\/\/doi.org\/10.1016\/j.celrep.2020.108399","journal-title":"Cell Rep"},{"key":"2436_CR47","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a032862","volume":"11","author":"ED Karousis","year":"2019","unstructured":"Karousis ED, M\u00fchlemann O (2019) Nonsense-mediated mRNA decay begins where translation ends. Cold Spring Harb Perspect Biol 11:a032862. https:\/\/doi.org\/10.1101\/cshperspect.a032862","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2436_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223954","volume":"14","author":"EJ Brasell","year":"2019","unstructured":"Brasell EJ, Chu LL, Akpa MM, Eshkar-Oren I, Alroy I, Corsini R, Gilfix BM, Yamanaka Y, Huertas P, Goodyer P (2019) The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis. PLoS ONE 14:e0223954. https:\/\/doi.org\/10.1371\/journal.pone.0223954","journal-title":"PLoS ONE"},{"key":"2436_CR49","doi-asserted-by":"publisher","first-page":"e52611.","DOI":"10.7554\/eLife.52611","volume":"9","author":"JR Wangen","year":"2020","unstructured":"Wangen JR, Green R (2020) Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides. eLife 9:e52611. https:\/\/doi.org\/10.7554\/eLife.52611","journal-title":"eLife"},{"key":"2436_CR50","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.1153252","volume":"320","author":"M Chahrour","year":"2008","unstructured":"Chahrour M, Jung SY, Shaw C, Zhou X, Wong STC, Qin J, Zoghbi HY (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320:1224\u20131229. https:\/\/doi.org\/10.1126\/science.1153252","journal-title":"Science"},{"key":"2436_CR51","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.celrep.2018.07.099","volume":"24","author":"MJ Lyst","year":"2018","unstructured":"Lyst MJ, Ekiert R, Guy J, Selfridge J, Koerner MV, Merusi C, De Sousa D, Bird A (2018) Affinity for DNA contributes to NLS independent nuclear localization of MeCP2. Cell Rep 24:2213\u20132220. https:\/\/doi.org\/10.1016\/j.celrep.2018.07.099","journal-title":"Cell Rep"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02436-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-024-02436-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02436-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T07:03:14Z","timestamp":1714201394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-024-02436-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,2]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["2436"],"URL":"https:\/\/doi.org\/10.1007\/s00109-024-02436-6","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,2]]},"assertion":[{"value":"13 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}